Optimierung der Hämostase

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network

Quelle‎: N Engl J Med 2017;376(2):136-48.

Indiziert‎: PubMed 27774838

DOI‎: 10.1056/NEJMoa1606424

http://www.ncbi.nlm.nih.gov/pubmed/27774838 (öffnet neues Fenster)

Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass. (öffnet neues Fenster)

Nurözler F, Kutlu T, Küçük G.

Quelle‎: Asian Cardiovasc Thorac Ann 2008;16(6):483-7.

Indiziert‎: PubMed 18984759

DOI‎: 10.1177/021849230801600611

https://www.ncbi.nlm.nih.gov/pubmed/18984759 (öffnet neues Fenster)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (öffnet neues Fenster)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Quelle‎: JAMA Surg 2013;148(6):538-47.

Indiziert‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (öffnet neues Fenster)

Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. (öffnet neues Fenster)

Shi J, Zhou C, Pan W, Sun H, Liu S, Feng W, Wang W, Cheng Z, Wang Y, Zheng Z

Quelle‎: JAMA. 2022;328(4):336-47.

Indiziert‎: PubMed 35881121

DOI‎: 10.1001/jama.2022.10725

https://pubmed.ncbi.nlm.nih.gov/35881121/ (öffnet neues Fenster)

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. (öffnet neues Fenster)

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Quelle‎: Anesth Analg 2012;115(2):239-43.

Indiziert‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

https://www.ncbi.nlm.nih.gov/pubmed/21737704 (öffnet neues Fenster)

Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. (öffnet neues Fenster)

Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Hu S.

Quelle‎: Ann Thorac Surg 2010;89(5):1489-95.

Indiziert‎: PubMed 20417766

DOI‎: 10.1016/j.athoracsur.2010.02.006

https://www.ncbi.nlm.nih.gov/pubmed/20417766 (öffnet neues Fenster)

Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study. (öffnet neues Fenster)

Øvrum E, Tangen G, Tølløfsrud S, Ringdal MA, Øystese R, Istad R.

Quelle‎: Interact Cardiovasc Thorac Surg 2010;10(4):545-8.

Indiziert‎: PubMed 20067988

DOI‎: 10.1510/icvts.2009.226613

https://www.ncbi.nlm.nih.gov/pubmed/20067988 (öffnet neues Fenster)

Rekombinanter Faktor VIIa (rFVIIa)

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? (öffnet neues Fenster)

Ballen J, Raabe M, Muirhead B.

Quelle‎: Can J Anaesth 2006;53(4):353-6.

Indiziert‎: PubMed 16575032

DOI‎: 10.1007/BF03022498

https://www.ncbi.nlm.nih.gov/pubmed/16575032 (öffnet neues Fenster)

Use of recombinant activated factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. (öffnet neues Fenster)

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

Quelle‎: Transfusion 2013;53(4):798-804.

Indiziert‎: PubMed 22845023

DOI‎: 10.1111/j.1537-2995.2012.03801.x

https://www.ncbi.nlm.nih.gov/pubmed/22845023 (öffnet neues Fenster)

Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. (öffnet neues Fenster)

Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.

Quelle‎: Ann Thorac Surg 2008;85(3):836-44.

Indiziert‎: PubMed 18291152

DOI‎: 10.1016/j.athoracsur.2007.06.076

https://www.ncbi.nlm.nih.gov/pubmed/18291152 (öffnet neues Fenster)

Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia. (öffnet neues Fenster)

Elmistekawy E, Lapierre H, Bourke M, Dennie C, Labinaz M, Ruel M.

Quelle‎: Can J Cardiol 2011;27(6):869.e7-8.

Indiziert‎: PubMed 21983113

DOI‎: 10.1016/j.cjca.2011.07.632

https://www.ncbi.nlm.nih.gov/pubmed/21983113 (öffnet neues Fenster)

Off-label use of recombinant activated factor VII for cardiac surgical bleeding. (öffnet neues Fenster)

Flynn BC, Steiner ME, Mazzeffi M

Quelle‎: Anesthesiology. 2023 1;139(2):197-210.

Indiziert‎: PubMed 37155359

DOI‎: 10.1097/ALN.0000000000004569

https://pubmed.ncbi.nlm.nih.gov/37155359/ (öffnet neues Fenster)

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. (öffnet neues Fenster)

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Quelle‎: Circulation 2009;120(1):21-7.

Indiziert‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

https://www.ncbi.nlm.nih.gov/pubmed/19546387 (öffnet neues Fenster)

Intraoperative use of recombinant activated factor VII during complex aortic surgery. (öffnet neues Fenster)

Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.

Quelle‎: J Thorac Cardiovasc Surg 2012;143(5):1198-204.

Indiziert‎: PubMed 22285329

DOI‎: 10.1016/j.jtcvs.2012.01.004

https://www.ncbi.nlm.nih.gov/pubmed/22285329 (öffnet neues Fenster)

Off-label use of recombinant human factor VIIa. (öffnet neues Fenster)

Goodnough LT, Levy JH.

Quelle‎: Ann Thorac Surg 2014;98(2):393-5.

Indiziert‎: PubMed 25087781

DOI‎: 10.1016/j.athoracsur.2014.06.007

https://www.ncbi.nlm.nih.gov/pubmed/25087781 (öffnet neues Fenster)

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). (öffnet neues Fenster)

Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.

Quelle‎: Eur J Cardiothorac Surg 2011;40(6):1320-7.

Indiziert‎: PubMed 21550261

DOI‎: 10.1016/j.ejcts.2011.03.032

https://www.ncbi.nlm.nih.gov/pubmed/21550261 (öffnet neues Fenster)

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. (öffnet neues Fenster)

Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TW, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM.

Quelle‎: Circulation 2008;118(4):331-8.

Indiziert‎: PubMed 18606914

DOI‎: 10.1161/CIRCULATIONAHA.108.764308

https://www.ncbi.nlm.nih.gov/pubmed/18606914 (öffnet neues Fenster)

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. (öffnet neues Fenster)

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Quelle‎: J Vasc Surg 2011;53(4):1032-7.

Indiziert‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

https://www.ncbi.nlm.nih.gov/pubmed/21215579 (öffnet neues Fenster)

Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. (öffnet neues Fenster)

Lau P, Ong V, Tan WT, Koh PL, Hartman M.

Quelle‎: Transfus Med Hemother 2012;39(2):139-50.

Indiziert‎: PubMed 22670132

DOI‎: 10.1159/000338034

https://www.ncbi.nlm.nih.gov/pubmed/22670132 (öffnet neues Fenster)

Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection. (öffnet neues Fenster)

Lehr EJ, Alford TJ, Wang SH.

Quelle‎: Heart Surg Forum 2010;13(5):E275-9.

Indiziert‎: PubMed 20961825

DOI‎: 10.1532/HSF98.20101027

https://www.ncbi.nlm.nih.gov/pubmed/20961825 (öffnet neues Fenster)

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. (öffnet neues Fenster)

Masud F, Bostan F, Chi E, Pass SE, Samir H, Stuebing K, Liebl MG.

Quelle‎: J Cardiothorac Vasc Anesth 2009;23(1):28-33.

Indiziert‎: PubMed 18948033

DOI‎: 10.1053/j.jvca.2008.08.003

https://www.ncbi.nlm.nih.gov/pubmed/18948033 (öffnet neues Fenster)

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery. (öffnet neues Fenster)

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM.

Quelle‎: Drugs R D 2015;15(2):187-94.

Indiziert‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

https://www.ncbi.nlm.nih.gov/pubmed/25862216 (öffnet neues Fenster)

Hemostatic management of severe thrombocytopenia in a patient undergoing pulmonic valve replacement. (öffnet neues Fenster)

Tanaka KA, Li P, McHugh SM, Subramaniam K.

Quelle‎: A A Case Rep 2015;5(1):3-5.

Indiziert‎: PubMed 26125690

DOI‎: 10.1213/XAA.0000000000000166

https://www.ncbi.nlm.nih.gov/pubmed/26125690 (öffnet neues Fenster)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (öffnet neues Fenster)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Quelle‎: Anesthesiology 2003;98(6):1513-5.

Indiziert‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (öffnet neues Fenster)

Recombinant activated factor VII in cardiac surgery: a systematic review. (öffnet neues Fenster)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Quelle‎: Ann Thorac Surg 2007;83(2):707-14.

Indiziert‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (öffnet neues Fenster)

Gerinnungsfaktorenkonzentrate

Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. (öffnet neues Fenster)

Alberts M, Bandarenko N, Gaca J, Lockhart E, Milano C, Alexander S, Linder D, Lombard FW, Welsby IJ.

Quelle‎: Transfusion 2014;54(5):1348-57.

Indiziert‎: PubMed 24898456

DOI‎: 10.1111/trf.12463

https://www.ncbi.nlm.nih.gov/pubmed/24898456 (öffnet neues Fenster)

Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. (öffnet neues Fenster)

Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F.

Quelle‎: Interact Cardiovasc Thorac Surg 2012;15(3):382-9.

Indiziert‎: PubMed 22623627

DOI‎: 10.1093/icvts/ivs224

https://www.ncbi.nlm.nih.gov/pubmed/22623627 (öffnet neues Fenster)

Reducing blood transfusion in aortic surgery: a novel approach. (öffnet neues Fenster)

Birla R, Nawaytou O, Shaw M, Jackson A, Mills K, Kuduvalli M, Field M, Agarwal S

Quelle‎: Ann Thorac Surg 2019;108(5):1369-75.

Indiziert‎: PubMed 31255616

DOI‎: 10.1016/j.athoracsur.2019.04.127

https://www.ncbi.nlm.nih.gov/pubmed/31255616 (öffnet neues Fenster)

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. (öffnet neues Fenster)

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA.

Quelle‎: Ann Thorac Surg 2009;88(5):1666-8.

Indiziert‎: PubMed 19853132

DOI‎: 10.1016/j.athoracsur.2009.03.095

https://www.ncbi.nlm.nih.gov/pubmed/19853132 (öffnet neues Fenster)

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. (öffnet neues Fenster)

Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C.

Quelle‎: Crit Care 2016;20:5.

Indiziert‎: PubMed 26738468

DOI‎: 10.1186/s13054-015-1172-6

https://www.ncbi.nlm.nih.gov/pubmed/26738468 (öffnet neues Fenster)

Bloodless orthotopic heart transplantation in a Jehovah's Witness. (öffnet neues Fenster)

Dallas T, Welsby I, Bottiger B, Milano C, Daneshmand M, Guinn N.

Quelle‎: A A Case Rep 2015;4(10):140-2.

Indiziert‎: PubMed 25974419

DOI‎: 10.1213/XAA.0000000000000067

https://www.ncbi.nlm.nih.gov/pubmed/25974419 (öffnet neues Fenster)

State of the art - how I manage coagulopathy in cardiac surgery patients. (öffnet neues Fenster)

Davidson S.

Quelle‎: Br J Haematol 2014;164(6):779-89.

Indiziert‎: PubMed 24450971

DOI‎: 10.1111/bjh.12746

https://www.ncbi.nlm.nih.gov/pubmed/24450971 (öffnet neues Fenster)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (öffnet neues Fenster)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Quelle‎: Anesthesiology 2011;115(6):1179-91.

Indiziert‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (öffnet neues Fenster)

Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. (öffnet neues Fenster)

Karkouti K, Bartoszko J, Grewal D, Bingley C, Armali C, Carroll J, Hucke HP, Kron A, McCluskey SA, Rao V, Callum J

Quelle‎: JAMA Netw Open 2021;4(4):e213936.

Indiziert‎: PubMed 33792729

DOI‎: 10.1001/jamanetworkopen.2021.3936

https://www.ncbi.nlm.nih.gov/pubmed/33792729 (öffnet neues Fenster)

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. (öffnet neues Fenster)

Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A.

Quelle‎: Thromb Haemost 2009;102(1):137-44.

Indiziert‎: PubMed 19572078

DOI‎: 10.1160/TH08-09-0587

https://www.ncbi.nlm.nih.gov/pubmed/19572078 (öffnet neues Fenster)

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. (öffnet neues Fenster)

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

Quelle‎: J Thorac Cardiovasc Surg 2013;145(3 Suppl):S178-85.

Indiziert‎: PubMed 23410777

DOI‎: 10.1016/j.jtcvs.2012.12.083

https://www.ncbi.nlm.nih.gov/pubmed/23410777 (öffnet neues Fenster)

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. (öffnet neues Fenster)

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Quelle‎: Anesthesiology 2013;118(1):40-50.

Indiziert‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

https://www.ncbi.nlm.nih.gov/pubmed/23249928 (öffnet neues Fenster)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (öffnet neues Fenster)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Quelle‎: J Am Heart Assoc 2015;4(6):e002066.

Indiziert‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (öffnet neues Fenster)

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). (öffnet neues Fenster)

Ranucci M, Baryshnikova E.

Quelle‎: Br J Anaesth 2016;116(5):618-23.

Indiziert‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

https://www.ncbi.nlm.nih.gov/pubmed/26893405 (öffnet neues Fenster)

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate. (öffnet neues Fenster)

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Quelle‎: Can J Anaesth 2012;59(3):299-303.

Indiziert‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

https://www.ncbi.nlm.nih.gov/pubmed/22161243 (öffnet neues Fenster)

Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. (öffnet neues Fenster)

Roman M, Biancari F, Ahmed AB, Agarwal S, Hadjinikolaou L, Al-Sarraf A, Tsang G, Oo AY, Field M, Santini F, Mariscalco G

Quelle‎: Ann Thorac Surg 2019;107(4):1275-83.

Indiziert‎: PubMed 30458156

DOI‎: 10.1016/j.athoracsur.2018.10.013

https://www.ncbi.nlm.nih.gov/pubmed/30458156 (öffnet neues Fenster)

Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. (öffnet neues Fenster)

Sniecinski RM, Chen EP, Levy JH, Szlam F, Tanaka KA.

Quelle‎: Anesth Analg 2007;104(4):763-5.

Indiziert‎: PubMed 17377078

DOI‎: 10.1213/01.ane.0000250913.45299.f3

https://www.ncbi.nlm.nih.gov/pubmed/17377078 (öffnet neues Fenster)

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. (öffnet neues Fenster)

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Quelle‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Indiziert‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

https://www.ncbi.nlm.nih.gov/pubmed/22233480 (öffnet neues Fenster)

Desmopressin

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. (öffnet neues Fenster)

Hanke AA, Dellweg C, Kienbaum P, Weber CF, Görlinger K, Rahe-Meyer N.

Quelle‎: Anaesthesia 2010;65(7):688-91.

Indiziert‎: PubMed 20477783

DOI‎: 10.1111/j.1365-2044.2010.06367.x

https://www.ncbi.nlm.nih.gov/pubmed/20477783 (öffnet neues Fenster)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (öffnet neues Fenster)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Quelle‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Indiziert‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (öffnet neues Fenster)

Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. (öffnet neues Fenster)

Wademan BH, Galvin SD.

Quelle‎: Interact Cardiovasc Thorac Surg 2014;18(3):360-70.

Indiziert‎: PubMed 24263581

DOI‎: 10.1093/icvts/ivt491

https://www.ncbi.nlm.nih.gov/pubmed/24263581 (öffnet neues Fenster)

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. (öffnet neues Fenster)

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

Quelle‎: Anesth Analg 2010;110(3):702-7.

Indiziert‎: PubMed 20042444

DOI‎: 10.1213/ANE.0b013e3181c92a5c

https://www.ncbi.nlm.nih.gov/pubmed/20042444 (öffnet neues Fenster)

Substanzen für die topische Blutstillung

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (öffnet neues Fenster)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Quelle‎: Ann Surg 2010;251(2):217-28.

Indiziert‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (öffnet neues Fenster)

A review of topical hemostatic agents for use in cardiac surgery. (öffnet neues Fenster)

Barnard J, Millner R.

Quelle‎: Ann Thorac Surg 2009;88(4):1377-83.

Indiziert‎: PubMed 19766855

DOI‎: 10.1016/j.athoracsur.2009.02.092

https://www.ncbi.nlm.nih.gov/pubmed/19766855 (öffnet neues Fenster)

Armentarium of topical hemostatic products in cardiovascular surgery: an update. (öffnet neues Fenster)

Forcillo J, Perrault LP.

Quelle‎: Transfus Apher Sci 2014;50(1):26-31.

Indiziert‎: PubMed 24412443

DOI‎: 10.1016/j.transci.2013.12.009

https://www.ncbi.nlm.nih.gov/pubmed/24412443 (öffnet neues Fenster)

A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. (öffnet neues Fenster)

Mani K, Campbell A, Fitzpatrick J, Modarai B, Carrell T, Rashid H, Zayed H.

Quelle‎: Eur J Vasc Endovasc Surg 2013;45(1):51-6.

Indiziert‎: PubMed 23134676

DOI‎: 10.1016/j.ejvs.2012.10.008

https://www.ncbi.nlm.nih.gov/pubmed/23134676 (öffnet neues Fenster)

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. (öffnet neues Fenster)

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Quelle‎: Innovations (Phila) 2012;7(4):229-41.

Indiziert‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

https://www.ncbi.nlm.nih.gov/pubmed/23123988 (öffnet neues Fenster)

Control of troublesome bleeding during repair of acute type A dissection with use of modified rapid deployment hemostat (MRDH). (öffnet neues Fenster)

Salerno TA, Gaughan C, Suarez M, Panos AL.

Quelle‎: J Card Surg 2009;24(6):722-4.

Indiziert‎: PubMed 20078720

DOI‎: 10.1111/j.1540-8191.2009.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/20078720 (öffnet neues Fenster)

Topical haemostatic agents. (öffnet neues Fenster)

Seyednejad H, Imani M, Jamieson T, Seifalian AM.

Quelle‎: Br J Surg 2008;95(10):1197-225.

Indiziert‎: PubMed 18763249

DOI‎: 10.1002/bjs.6357

https://www.ncbi.nlm.nih.gov/pubmed/18763249 (öffnet neues Fenster)

Viskoelastische Tests zur Identifizierung chirurgischer oder koagulopathischer Blutungen

An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. (öffnet neues Fenster)

Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W.

Quelle‎: Transfus Med 2006;16(1):31-9.

Indiziert‎: PubMed 16480437

DOI‎: 10.1111/j.1365-3148.2006.00645.x

https://www.ncbi.nlm.nih.gov/pubmed/16480437 (öffnet neues Fenster)

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. (öffnet neues Fenster)

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Quelle‎: Anesthesiology 2011;115(6):1179-91.

Indiziert‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

https://www.ncbi.nlm.nih.gov/pubmed/21970887 (öffnet neues Fenster)

Management of hemorrhage in cardiothoracic surgery. (öffnet neues Fenster)

Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA.

Quelle‎: J Cardiothorac Vasc Anesth 2013;27(4 Suppl):S20-34.

Indiziert‎: PubMed 23910533

DOI‎: 10.1053/j.jvca.2013.05.014

https://www.ncbi.nlm.nih.gov/pubmed/23910533 (öffnet neues Fenster)

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. (öffnet neues Fenster)

Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K.

Quelle‎: Anesthesiology 2012;117(3):531-47.

Indiziert‎: PubMed 22914710

DOI‎: 10.1097/ALN.0b013e318264c644

https://www.ncbi.nlm.nih.gov/pubmed/22914710 (öffnet neues Fenster)

HERZ-, THORAX- UND GEFÄßCHIRURGIE

Optimierung der Hämostase

Deutsch

Optimierung der Hämostase

https://assetsnffrgf-a.akamaihd.net/assets/ct/1add6d1d93/images/syn_placeholder_sqr.png

Antifibrinolytika

Rekombinanter Faktor VIIa (rFVIIa)

Gerinnungsfaktorenkonzentrate

Desmopressin

Substanzen für die topische Blutstillung

Viskoelastische Tests zur Identifizierung chirurgischer oder koagulopathischer Blutungen

Wähle deine Sprache aus

Teilen